Accrued Expenses

3 Months Ended

Mar. 31, 2023

Accrued Expenses

Accrued Expenses

Note 5. Accrued Expenses

At March 31, 2023 and December 31, 2022, accrued expenses consisted of the following:

	March 31,		December 31,
($ in thousands)	2023		2022
Payroll and related costs	$	339	$	1,886
Clinical and nonclinical trial expenses		1,576		2,106
Professional and consulting fees		1,041		1,637
Restructuring and other costs (1)		2,882		2,327
Acquisition-related costs		1,144		1,666
Other		216		289
Total accrued expenses	$	7,198	$	9,911

(1) Includes $1.3 million of severance due to two former executives payable in stock.